-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, LtObhlvGW/Xoq/pwT9WF3NThlpcMrlY7GKOesuw7HCxIPNXXRIDtF74cUZ/f6Zgu uhfjDpQLc1ieI0o55xGuiA== 0001257957-10-000010.txt : 20100211 0001257957-10-000010.hdr.sgml : 20100211 20100211203159 ACCESSION NUMBER: 0001257957-10-000010 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20100209 FILED AS OF DATE: 20100211 DATE AS OF CHANGE: 20100211 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AVI BIOPHARMA INC CENTRAL INDEX KEY: 0000873303 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 930797222 STATE OF INCORPORATION: OR FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE SW COLUMBIA STREET 2: STE 1105 CITY: PORTLAND STATE: OR ZIP: 97258 BUSINESS PHONE: 5032270554 MAIL ADDRESS: STREET 1: ONE SW COLUMBIA STREET 2: SUITE 1105 CITY: PORTLAND STATE: OR ZIP: 97258 FORMER COMPANY: FORMER CONFORMED NAME: ANTIVIRALS INC DATE OF NAME CHANGE: 19970123 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: IVERSEN PATRICK L CENTRAL INDEX KEY: 0001240570 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14895 FILM NUMBER: 10593738 MAIL ADDRESS: STREET 1: 4575 S W RESEARCH WAY STREET 2: SUITE 200 CITY: CORVALLIS STATE: OR ZIP: 97333 4 1 edgardoc.xml PRIMARY DOCUMENT X0303 4 2010-02-09 0 0000873303 AVI BIOPHARMA INC AVII 0001240570 IVERSEN PATRICK L 4575 SW RESEARCH WAY, SUITE 200 CORVALLIS OR 97333 0 1 0 0 Sr VP of Research & Devlopment Common Stock 86303 D Common Stock 3000 I by Spouse Common Stock 6000 I by Trust Incentive Stock Option (right to buy) 1.45 2010-02-09 4 A 0 103850 0 A 2011-02-09 2020-02-09 Common Stock 103850 103850 D Non-Qualified Stock Option (right to buy) 1.45 2010-02-09 4 A 0 16150 0 A 2011-02-09 2020-02-09 Common Stock 16150 16150 D Incentive Stock Option (right to buy) 0.92 2010-02-10 2019-02-10 Common Stock 66667 66667 D Incentive Stock Option (right to buy) 1.39 2009-02-28 2018-02-28 Common Stock 25000 25000 D Incentive Stock Option (right to buy) 2.53 2006-02-22 2015-02-22 Common Stock 75000 75000 D Incentive Stock Option (right to buy) 3 2009-02-06 2017-02-06 Common Stock 33334 33334 D Incentive Stock Option (right to buy) 5.35 2004-12-05 2012-12-05 Common Stock 37382 37382 D Incentive Stock Option (right to buy) 5.75 2001-01-03 2010-01-03 Common Stock 25960 25960 D Incentive Stock Option (right to buy) 7.35 2007-02-16 2016-02-16 Common Stock 23605 23605 D Non-Qualified Stock Option (right to buy) 0.92 2010-02-10 2019-02-10 Common Stock 33333 33333 D Non-Qualified Stock Option (right to buy) 1.39 2009-02-28 2018-02-28 Common Stock 50000 50000 D Non-Qualified Stock Option (right to buy) 3 2008-02-06 2017-02-06 Common Stock 91666 91666 D Non-Qualified Stock Option (right to buy) 5.35 2003-12-05 2012-12-05 Common Stock 55018 55018 D Non-Qualified Stock Option (right to buy) 5.75 2001-01-03 2010-01-03 Common Stock 58040 58040 D Non-Qualified Stock Option (right to buy) 7.35 2007-02-16 2016-02-16 Common Stock 51395 51395 D The Stock Option Grant vest as follows: 1/3 vest one year from date of grant and 1/3 each year thereafter until all shares vest three years from grant date. Price not required on initial report of stock option granted. Patrick L. Iversen 2010-02-11 -----END PRIVACY-ENHANCED MESSAGE-----